These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26359221)

  • 21. Repurposing metformin for the prevention of cancer and cancer recurrence.
    Heckman-Stoddard BM; DeCensi A; Sahasrabuddhe VV; Ford LG
    Diabetologia; 2017 Sep; 60(9):1639-1647. PubMed ID: 28776080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
    Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
    Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin: multi-faceted protection against cancer.
    Del Barco S; Vazquez-Martin A; Cufí S; Oliveras-Ferraros C; Bosch-Barrera J; Joven J; Martin-Castillo B; Menendez JA
    Oncotarget; 2011 Dec; 2(12):896-917. PubMed ID: 22203527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin in lung cancer: rationale for a combination therapy.
    Morgillo F; Sasso FC; Della Corte CM; Festino L; Manzo A; Martinelli E; Troiani T; Capuano A; Ciardiello F
    Expert Opin Investig Drugs; 2013 Nov; 22(11):1401-9. PubMed ID: 23937224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of previous diabetes therapy on tumor receptor phenotype in breast cancer: comparison of metformin and sulphonylurea derivatives].
    Bershteĭn LM; Boriakina MP; Turkevich EA; Tsyrlina EV; Semiglazov VF
    Vopr Onkol; 2010; 56(3):312-6. PubMed ID: 20804053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin does not alter the risk of lung cancer: a case-control analysis.
    Bodmer M; Becker C; Jick SS; Meier CR
    Lung Cancer; 2012 Nov; 78(2):133-7. PubMed ID: 22959242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin exposure and disseminated disease in patients with colorectal cancer.
    Spillane S; Bennett K; Sharp L; Barron TI
    Cancer Epidemiol; 2014 Feb; 38(1):79-84. PubMed ID: 24397977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin use and prostate cancer risk.
    Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
    Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin and survival in diabetic patients with breast cancer.
    El-Benhawy SA; El-Sheredy HG
    J Egypt Public Health Assoc; 2014 Dec; 89(3):148-53. PubMed ID: 25534180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer.
    Klubo-Gwiezdzinska J; Costello J; Patel A; Bauer A; Jensen K; Mete M; Burman KD; Wartofsky L; Vasko V
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3269-79. PubMed ID: 23709654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.
    Guarino E; Nigi L; Patti A; Fondelli C; Dotta F
    Expert Opin Pharmacother; 2012 Jun; 13(9):1377-84. PubMed ID: 22397507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antidiabetic therapy--a new possibility in the complex therapy of cancer?].
    Bánhegyi RJ; Rus-Gal PO; Nagy AK; Martyin T; Wágner R; Varga R; Pikó B
    Magy Onkol; 2010 Dec; 54(4):315-23. PubMed ID: 21163762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of metformin for patients with type 1 diabetes mellitus: a meta-analysis.
    Liu C; Wu D; Zheng X; Li P; Li L
    Diabetes Technol Ther; 2015 Feb; 17(2):142-8. PubMed ID: 25369141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
    Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting.
    Geraldine N; Marc A; Carla T; Chantal M; Stefaan B; Welcome W; Frank B
    Diabetes Res Clin Pract; 2012 Aug; 97(2):331-6. PubMed ID: 22386769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of metformin dose on cancer risk reduction in patients with type 2 diabetes mellitus: a 6-year follow-up study.
    Lin HC; Kachingwe BH; Lin HL; Cheng HW; Uang YS; Wang LH
    Pharmacotherapy; 2014 Jan; 34(1):36-45. PubMed ID: 23864581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects.
    Pierotti MA; Berrino F; Gariboldi M; Melani C; Mogavero A; Negri T; Pasanisi P; Pilotti S
    Oncogene; 2013 Mar; 32(12):1475-87. PubMed ID: 22665053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.